Follow-up Trials
Field trials to evaluate the efficacy and safety of GUMBOHATCH® vaccine

Field trials to evaluate the efficacy and safety of GUMBOHATCH® vaccine
The present trial was performed with the aim of comparing the efficacy of GUMBOHATCH® vs an HVT-IBD vaccine on a commercial farm in Peru where variant IBDV (vIBDV) circulation had been detected and was already causing problems in terms of productive parameters.
The present farm follow-up trial was performed with the aim of evaluating the safety and efficacy of GUMBOHATCH® when administered in layers via the subcutaneous route under field conditions within a company in Indonesia.
The present multi-farm follow-up trial was performed with the aim of evaluating the safety and efficacy of GUMBOHATCH® when administered via the in-ovo route under field conditions within a large company in Spain.
The present multi-farm follow-up trial was performed with the aim of comparing the safety and efficacy of GUMBOHATCH® when administered via the in-ovo route under field conditions compared with a standard-formulated immunocomplex vaccine in Spain.
The present multi-farm follow-up tria! was performed with the aim ol evaluating the salety and efficacy of GUMBOHATCH® when administered via the subcutaneous route under field conditions within a large company in Spain compared to a standard-formulated immune complex vaccine.
WEBINARS
Don´t miss our webinars on Infectious Bursal disease
Don't miss any updates
Controller: LABORATORIOS HIPRA, S.A.
Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
Lawful basis: Performance of the contractual relationship and HIPRA’s legitimate Interest.
Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.
For further information, please check our detailed information on Data Protection.